reference/27586099

http://rdf.ncbi.nlm.nih.gov/pubchem/reference/27586099

Outgoing Links

Predicate	Object
contentType	Journal Article\|Research Support, N.I.H., Extramural\|Research Support, Non-U.S. Gov't
endingPage	2544
issn	1557-3265 1078-0432
issueIdentifier	9
pageRange	2534-2544
publicationName	Clinical cancer research : an official journal of the American Association for Cancer Research
startingPage	2534
hasFundingAgency	http://rdf.ncbi.nlm.nih.gov/pubchem/organization/MD5_b5ad88fdb9d8a30d34a9b7f844c05af4
isSupportedBy	http://rdf.ncbi.nlm.nih.gov/pubchem/grant/MD5_d4c849feaf752940d4d043f0281dc04c http://rdf.ncbi.nlm.nih.gov/pubchem/grant/MD5_b6e2c3462d9aff42bb6c2d7d036df9fc
bibliographicCitation	Petrich AM, Leshchenko V, Kuo PY, Xia B, Thirukonda VK, Ulahannan N, Gordon S, Fazzari MJ, Ye BH, Sparano JA, Parekh S. Akt inhibitors MK-2206 and nelfinavir overcome mTOR inhibitor resistance in diffuse large B-cell lymphoma. Clin Cancer Res. 2012 May 01;18(9):2534–44. PMID: 22338016; PMCID: PMC3889476.
creator	http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_e20faa65f3bd14d4b2296c44dd9601de http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_814e714f0636f43d707ac921a57a6bb1 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_26d7b4d0a747866517eb9aaca79086c1 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_88120d66bc2a9db814d414019c477cd5 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_73b77b34d0b9cc4c7dc852b2f49b08d1 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_c40bfd278b4368f0fc9fad5b0a29aeb2 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_a3209067e1fab774c267c4eca28e6208 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_89e0932f40d019ed84232f121042e064 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_0e1a47916bf64a8ea921bed24a86f379 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_aab9cc099a75c56927413af39f3fa0db http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_b25c44c810b6372b38e5e4d8ea99c290
date	2012-04-30-04:00^^<http://www.w3.org/2001/XMLSchema#date>
identifier	https://pubmed.ncbi.nlm.nih.gov/PMC3889476 https://pubmed.ncbi.nlm.nih.gov/22338016 https://doi.org/10.1158/1078-0432.ccr-11-1407
isPartOf	http://rdf.ncbi.nlm.nih.gov/pubchem/journal/8794 https://portal.issn.org/resource/ISSN/1078-0432 https://portal.issn.org/resource/ISSN/1557-3265
language	English
source	https://www.crossref.org/ https://pubmed.ncbi.nlm.nih.gov/
title	Akt Inhibitors MK-2206 and Nelfinavir Overcome mTOR Inhibitor Resistance in Diffuse Large B-cell Lymphoma
discusses	http://id.nlm.nih.gov/mesh/M0029531 http://id.nlm.nih.gov/mesh/M0010294 http://id.nlm.nih.gov/mesh/M0026300 http://id.nlm.nih.gov/mesh/M000649677 http://id.nlm.nih.gov/mesh/M0457532 http://id.nlm.nih.gov/mesh/M0150739 http://id.nlm.nih.gov/mesh/M0545904 http://id.nlm.nih.gov/mesh/M0029863 http://id.nlm.nih.gov/mesh/M0019167 http://id.nlm.nih.gov/mesh/M0469193 http://id.nlm.nih.gov/mesh/M0543256 http://id.nlm.nih.gov/mesh/M0022149
hasPrimarySubjectTerm	http://id.nlm.nih.gov/mesh/D051057Q000037 http://id.nlm.nih.gov/mesh/D019008Q000187 http://id.nlm.nih.gov/mesh/D006575Q000494 http://id.nlm.nih.gov/mesh/D058570Q000037 http://id.nlm.nih.gov/mesh/D015398Q000187 http://id.nlm.nih.gov/mesh/D016403Q000188 http://id.nlm.nih.gov/mesh/D019888Q000494
hasSubjectTerm	http://id.nlm.nih.gov/mesh/D010766Q000187 http://id.nlm.nih.gov/mesh/D020869 http://id.nlm.nih.gov/mesh/D049109Q000187 http://id.nlm.nih.gov/mesh/D047428Q000494 http://id.nlm.nih.gov/mesh/D019869Q000378 http://id.nlm.nih.gov/mesh/D060888 http://id.nlm.nih.gov/mesh/D058570Q000378 http://id.nlm.nih.gov/mesh/D051057Q000378 http://id.nlm.nih.gov/mesh/D020133 http://id.nlm.nih.gov/mesh/D016403Q000378 http://id.nlm.nih.gov/mesh/D000081082 http://id.nlm.nih.gov/mesh/D014408Q000235 http://id.nlm.nih.gov/mesh/D015153 http://id.nlm.nih.gov/mesh/D020123Q000494 http://id.nlm.nih.gov/mesh/D014408Q000378 http://id.nlm.nih.gov/mesh/D005434 http://id.nlm.nih.gov/mesh/D045744 http://id.nlm.nih.gov/mesh/D017320Q000494 http://id.nlm.nih.gov/mesh/D005455 http://id.nlm.nih.gov/mesh/D006801 http://id.nlm.nih.gov/mesh/D017209Q000187 http://id.nlm.nih.gov/mesh/D016403Q000473 http://id.nlm.nih.gov/mesh/D007124 http://id.nlm.nih.gov/mesh/D020411 http://id.nlm.nih.gov/mesh/D012333Q000235
discussesAsDerivedByTextMining	http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID24964624 http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID11449 http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID5284616 http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID64143 http://rdf.ncbi.nlm.nih.gov/pubchem/gene/MD5_472b28cee6c37ce9d58de4aa1dc6d7ef http://rdf.ncbi.nlm.nih.gov/pubchem/gene/MD5_fe0d872c4ea3e7d9f07488fc82841cc8 http://rdf.ncbi.nlm.nih.gov/pubchem/gene/MD5_d0bb789479d34dbc0811f92fc2bc5049 http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID9859

Incoming Links

Predicate	Subject
isDiscussedBy	http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID128993952 http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID128132375 http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID248766214 http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID248184126

Total number of triples: 90.